Ken Griffin Organon & Co. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Organon & Co. stock. As of the latest transaction made, Citadel Advisors LLC holds 318,300 shares of OGN stock, worth $4.97 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
318,300
Previous 318,500
0.06%
Holding current value
$4.97 Million
Previous $5.99 Million
10.04%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding OGN
# of Institutions
775Shares Held
192MCall Options Held
2.11MPut Options Held
909K-
Black Rock Inc. New York, NY32.6MShares$509 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$471 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.76MShares$152 Million0.06% of portfolio
-
State Street Corp Boston, MA9.01MShares$141 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL7.49MShares$117 Million0.31% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $3.97B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...